Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 1/20 | 0.52 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.42 |
| ▸ | CCR1 | P32246 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 2/20 | 0.36 |
| ▸ | HTR2C | P28335 | 2/20 | 0.36 |
| ▸ | HTR7 | P34969 | 1/20 | 0.36 |
| ▸ | DHODH | Q02127 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14720787 | 0.86 | SRD5A2 (0.43) | MCHR1SRD5A2HRH3HTR2AHTR2C | |
| SCHEMBL14720777 | 0.84 | MCHR1 (0.44) | MCHR1SRD5A2HRH3HTR2AHTR2C | |
| SCHEMBL14720591 | 0.80 | SRD5A2 (0.44) | MCHR1SRD5A2HRH3HTR2AHTR2C | |
| SCHEMBL14720717 | 0.79 | SRD5A2 (0.43) | MCHR1SRD5A2HRH3HTR2AHTR2C | |
| SCHEMBL14720998 | 0.79 | SRD5A2 (0.57) | MCHR1SRD5A2HRH3DHODHSRD5A1 | |
| SCHEMBL14720425 | 0.76 | DHODH (0.40) | MCHR1SRD5A2HRH3DHODHSRD5A1 | |
| SCHEMBL20333309 | 0.76 | MCHR1 (0.46) | MCHR1HTR2AHTR2CCYP1A2 | |
| SCHEMBL14720542 | 0.76 | MCHR1 (0.56) | MCHR1HTR2AHTR2CHTR7 | |
| SCHEMBL20305006 | 0.74 | SRD5A2 (0.54) | MCHR1SRD5A2HTR2AHTR2C | |
| SCHEMBL14721037 | 0.72 | SRD5A2 (0.47) | MCHR1SRD5A2DHODHSRD5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013027001-A1 | COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-02-28 | — | — | WO | claimed |
| WO-2013027001-A1 | COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-02-28 | — | — | WO | disclosed |
| WO-2013027001-A1 | COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-02-28 | — | — | WO | disclosed |